However, basally high levels of linker phosphorylation of Smad3 were already evident in the malignant M3 cells, which nevertheless still retain their tumor suppressive responses to TGF-β (Figure 1E), so loss of tumor suppression in M4 cells cannot be due to de novo Smad3 linker phosphorylation. The gene discussed is SMAD3; the disease is neoplasm.